Your search returned 2 results.

Results
	1.	Inhibition of PARP-1 by olaparib (AZD2281) increases the radiosensitivity of a lung tumor xenograft. [electronic resource] by Senra, Joana M Telfer, Brian A Cherry, Kim E McCrudden, Cian M Hirst, David G O'Connor, Mark J Wedge, Stephen R Stratford, Ian J Producer: 20120413 In: Molecular cancer therapeutics vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. [electronic resource] by McCrudden, Cian M O'Rourke, Martin G Cherry, Kim E Yuen, Hiu-Fung O'Rourke, Declan Babur, Muhammad Telfer, Brian A Thomas, Huw D Keane, Patrick Nambirajan, Thiagarajan Hagan, Chris O'Sullivan, Joe M Shaw, Chris Williams, Kaye J Curtin, Nicola J Hirst, David G Robson, Tracy Producer: 20160108 In: PloS one vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search